Global Life Sciences Business News: Topic Synopsis
Finglobenewshour presents Global Life Sciences Business News: Topic Synopsis, a succinct report that chooses one most important developing news related to any global life sciences company or set of companies during a specific period and provides a panoramic view on the same. Each such synopsis covers all aspects of this particular current issue and delves in depth, analyzes, and then presents a brief synopsis.
Highlights:
-
➢ Focuses on the most crucial one topic during a given specific period
➢ The entire period’s developments summarized for this topic
➢ Scans all the important media viewpoints
➢ Provides views from all relevant aspects
➢ Briefly analyzes with an unbiased independent approach
➢ Suggests the expected direction that this topic would take
Key features:
-
➢ Presents in one nutshell the entire topic
➢ Any development missed during the specific period can be found in this report
➢ No need to browse various media stories, thus, saves time
➢ A complete picture of the key topic
Completed 10 topics synopses (October -2016):
- 401. Healthcare start-ups attracting an increase in investments
- 402. ‘Genomes’ majorly engaging Life Science companies worldwide
- 403. Pharma sector witnessing a rise in mergers
- 404. Acquisitions making in-roads as an important healthcare investment strategy
- 405. Orphan drugs pricing issues continue to raise concerns
- 406. China’s drug production regulations undergoing changes
- 407. Pharma companies from China planning to enter India
- 408. New opportunities in Japan healthcare sector for nurses and caregivers from India
- 409. Japan and India to intensify collaborative efforts in medical/pharma industry
- 410. Indian pharma firms seeking to gain foothold in Japan
Selected topics synopses (November -2016):
- 411. US-China Pharma sector need to iron out issues
- 412. Radiopharmacy networks gaining ground
- 413. Pharma companies target emerging markets for next big growth
- 414. India concerned over dependence on China for key pharma raw material
More will be selected during November-2016:
- 415:
- 416:
- 417:
- 418:
- 419:
- 420:
Subscription Fees:
- $10 for 1 topic synopsis
- $40 for 5 topic synopsis ($8 per topic synopsis)
- $60 for 10 topic synopsis ($6 per topic synopsis)
Please send us an email for any further queries to info@finglobenewshour.com.